Discovery is the key to advancing human health. Find out how our leading researchers are pioneering new, breakthrough solutions to some of the world’s most challenging health problems.
The funding will support the establishment of a research centre that will significantly expand the university’s capacity for research, partnerships and training to drive new therapies to market.
The funding will support McMaster startups BiCova Therapeutics and PROVA Innovations as they develop and commercialize their health technologies.
In a groundbreaking study, McMaster researchers have identified a potential treatment for Sandhoff and Tay-Sachs diseases — two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and spinal cord.
McMaster logo
